Literature DB >> 25557874

Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth.

Jenni A Tamminen1, Miao Yin1, Mikko Rönty2, Eva Sutinen3, Arja Pasternack4, Olli Ritvos4, Marjukka Myllärniemi5, Katri Koli6.   

Abstract

Activin-A and activin-B, members of the TGF-β superfamily, are regulators of reproductive functions, inflammation and wound healing. These dimeric molecules regulate various cellular activities such as proliferation, migration and suvival. Malignant mesothelioma is an asbestos exposure related tumor affecting mainly pleura and it usually has a dismal prognosis. Here, we demonstrate that both activin-A and -B are abundantly expressed in mesothelioma tumor tissue as well as in cultured primary and established mesothelioma cells. Migratory and invasive mesothelioma cells were also found to have attenuated activation of the Smad2/3 pathway in response to activins. Migration and invasive growth of the cells in three-dimentional matrix was prevented by inhibition of activin activity using a soluble activin receptor 2B (sActR2B-Fc). This was associated with decreased ERK activity. Furthermore, migration and invasive growth was significantly inhibited by blocking ERK phosphorylation. Mesothelioma tumors are locally invasive and our results clearly suggest that acivins have a tumor-promoting function in mesothelioma through increasing expression and switching from canonical Smad3 pathway to non-canonical ERK pathway signaling. Blocking activin activity offers a new therapeutic approach for inhibition of mesothelioma invasive growth.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activin; Invasive growth; Mesothelioma

Mesh:

Substances:

Year:  2014        PMID: 25557874     DOI: 10.1016/j.yexcr.2014.12.010

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

Review 1.  Different Immunoregulation Roles of Activin A Compared With TGF-β.

Authors:  Fanglin Li; Yiru Long; Xiaolu Yu; Yongliang Tong; Likun Gong
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

2.  Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells.

Authors:  Holli A Loomans; Shanna A Arnold; Laura L Quast; Claudia D Andl
Journal:  BMC Cancer       Date:  2016-11-09       Impact factor: 4.430

3.  Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma.

Authors:  Miao Yin; Mira Tissari; Jenni Tamminen; Irene Ylivinkka; Mikko Rönty; Pernilla von Nandelstadh; Kaisa Lehti; Marko Hyytiäinen; Marjukka Myllärniemi; Katri Koli
Journal:  Oncotarget       Date:  2017-10-06

4.  Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.

Authors:  Yoshiya Ohno; Serina Shingyoku; Sakina Miyake; Aya Tanaka; Sena Fudesaka; Yuta Shimizu; Ai Yoshifuji; Yuki Yamawaki; Sachiyo Yoshida; Saya Tanaka; Kazuma Sakura; Toshiyuki Tanaka
Journal:  Oncogene       Date:  2018-07-30       Impact factor: 9.867

5.  A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.

Authors:  Gabriel Mak; Jean-Charles Soria; Sarah P Blagden; Ruth Plummer; Ronald A Fleming; Noelia Nebot; Jianping Zhang; Jolly Mazumdar; Debra Rogan; Anas Gazzah; Ivana Rizzuto; Alastair Greystoke; Li Yan; Jerry Tolson; Kurt R Auger; Hendrik-Tobias Arkenau
Journal:  Br J Cancer       Date:  2019-04-17       Impact factor: 7.640

6.  ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.

Authors:  Federica Portale; Giulia Cricrì; Silvia Bresolin; Monica Lupi; Stefania Gaspari; Daniela Silvestri; Barbara Russo; Noemi Marino; Paolo Ubezio; Fabio Pagni; Patrizia Vergani; Geertruy Te Kronnie; Maria Grazia Valsecchi; Franco Locatelli; Carmelo Rizzari; Andrea Biondi; Erica Dander; Giovanna D'Amico
Journal:  Haematologica       Date:  2018-09-27       Impact factor: 9.941

7.  PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.

Authors:  M Lizeth Orozco Morales; Catherine A Rinaldi; Emma de Jong; Sally M Lansley; Joel P A Gummer; Bence Olasz; Shabarinath Nambiar; Danika E Hope; Thomas H Casey; Y C Gary Lee; Connull Leslie; Gareth Nealon; David M Shackleford; Andrew K Powell; Marina Grimaldi; Patrick Balaguer; Rachael M Zemek; Anthony Bosco; Matthew J Piggott; Alice Vrielink; Richard A Lake; W Joost Lesterhuis
Journal:  iScience       Date:  2021-12-04

8.  Activin B promotes endometrial cancer cell migration by down-regulating E-cadherin via SMAD-independent MEK-ERK1/2-SNAIL signaling.

Authors:  Siyuan Xiong; Christian Klausen; Jung-Chien Cheng; Peter C K Leung
Journal:  Oncotarget       Date:  2016-06-28

9.  Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.

Authors:  Chang Li; Veronika Rezov; Emmi Joensuu; Ville Vartiainen; Mikko Rönty; Miao Yin; Marjukka Myllärniemi; Katri Koli
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

10.  INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.

Authors:  Jinpeng Yuan; Aosi Xie; Qiangjian Cao; Xinxin Li; Juntian Chen
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.